#healthcare #medicine #ethics To view or add a comment, sign in GLP-1 storm is upon us from tomorrow So the GLP-1 floodgates open on Mar 20th with 50+ companies expected to launch their brands upon the patent expiry
B., Sitta, A., Deon, M., Wajner, M., and Vargas, C
For patients with MASH, clinical trials have demonstrated histological improvements in liver inflammation and ballooning degeneration
The reason is what doctors call a washout period, allowing the drug to fully leave the body
A weekly injection, a monthly check-in, and labs that prove what's happening underneath
Although it continues to attract interest in peptide medicine communities, the clinical research remains limited and somewhat controversial